Key Takeaways
- • Private equity firms have substantially expanded control over ambulatory surgery centers (ASCs), which now account for more than 60% of U.S. outpatient procedural care and represent an approximately $30 billion market, according to a report from the nonprofit Private Equity Stakeholder Project (PESP).
- • KKR's 2018 leveraged buyout of Envision Healthcare (parent of AmSurg) for $9.9 billion, financed with over $7 billion in debt, exemplifies the consolidation risks: Envision filed for Chapter 11 bankruptcy in 2023, and Ascension acquired AmSurg in 2025 for $3.9 billion, consolidating more than 250 ASCs under a nonprofit health system.
- • Private equity strategies in ASCs raise material concerns around debt leverage, transparency, ownership consolidation, and the intersection with nonprofit health systems and vertically integrated insurance companies—areas that currently lack adequate regulatory oversight, according to PESP senior policy researcher Michael Fenne.
- • Over the past decade, private equity firms have systematically expanded ASC presence through targeted acquisitions, platform building, and strategic joint ventures, increasingly shaping how these facilities are owned, operated, and financed.
Summary
Private equity investment in ambulatory surgery centers has reached a critical inflection point, with PE-backed firms now exerting substantial influence over a $30 billion market segment that delivers more than 60% of outpatient procedural care in the United States. According to a research brief from the Private Equity Stakeholder Project (PESP), the consolidation trend reflects a decade-long pattern of targeted acquisitions, platform building, and strategic investments that have fundamentally altered the ownership and operational structure of the ASC industry.
The most instructive case study involves KKR's 2018 acquisition of Envision Healthcare, the parent company of AmSurg, which was then the largest standalone ASC operator. The $9.9 billion leveraged buyout was financed with more than $7 billion in debt—a capital structure that ultimately proved unsustainable. Envision filed for Chapter 11 bankruptcy in 2023, demonstrating the downside risks of aggressive debt-financed healthcare acquisitions. In 2025, nonprofit health system Ascension acquired AmSurg for $3.9 billion, consolidating operational control over more than 250 ASCs.
Michael Fenne, senior policy researcher at PESP and author of the report, emphasized that private equity firms are "increasingly shaping how these facilities are owned, operated, and financed." The report identifies material risks spanning debt leverage, transparency deficiencies, and horizontal consolidation within the sector. Additionally, PESP highlights understudied intersections between private equity strategies and nonprofit health systems, as well as vertically integrated insurance companies—areas that currently operate with limited regulatory scrutiny.
The consolidation pattern signals a structural shift in healthcare delivery infrastructure, with PE-backed operators expanding influence through both direct ownership and partnership arrangements. The Envision-AmSurg trajectory, while illustrative of leverage risk, does not appear to have deterred PE capital deployment into the sector, suggesting continued investment appetite despite demonstrated distress scenarios.
The most instructive case study involves KKR's 2018 acquisition of Envision Healthcare, the parent company of AmSurg, which was then the largest standalone ASC operator. The $9.9 billion leveraged buyout was financed with more than $7 billion in debt—a capital structure that ultimately proved unsustainable. Envision filed for Chapter 11 bankruptcy in 2023, demonstrating the downside risks of aggressive debt-financed healthcare acquisitions. In 2025, nonprofit health system Ascension acquired AmSurg for $3.9 billion, consolidating operational control over more than 250 ASCs.
Michael Fenne, senior policy researcher at PESP and author of the report, emphasized that private equity firms are "increasingly shaping how these facilities are owned, operated, and financed." The report identifies material risks spanning debt leverage, transparency deficiencies, and horizontal consolidation within the sector. Additionally, PESP highlights understudied intersections between private equity strategies and nonprofit health systems, as well as vertically integrated insurance companies—areas that currently operate with limited regulatory scrutiny.
The consolidation pattern signals a structural shift in healthcare delivery infrastructure, with PE-backed operators expanding influence through both direct ownership and partnership arrangements. The Envision-AmSurg trajectory, while illustrative of leverage risk, does not appear to have deterred PE capital deployment into the sector, suggesting continued investment appetite despite demonstrated distress scenarios.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.